About
Pain Treatment
Areas of Focus
Categories
Small Molecule PharmaceuticalSoutheastern U.S.
Clinical Trials (8)
View allTotal Trials
8
As Lead Sponsor
8
As Collaborator
0
Total Enrollment
694
By Phase
PHASE2: 5PHASE1/PHASE2: 1PHASE2/PHASE3: 2
By Status
COMPLETED: 5RECRUITING: 2WITHDRAWN: 1
Clinical Trials Pipeline8 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT05685225Lead Sponsor
Single-Site Study of Naltrexone/Acetaminophen for the Acute Treatment of Migraine: A Phase 2 Randomized Trial
PHASE2Recruiting
300 participants
Started: Jan 31, 2025 · Completed: Dec 31, 2026
NCT06277219Lead Sponsor
A First-in-Human, Phase 1/2 Study of LAT010 in Patients With Advanced Solid Tumors (LIGHTSPEED-1)
PHASE1/PHASE2Recruiting
150 participants
Started: Jun 5, 2024 · Completed: Mar 31, 2027
NCT03194555Lead Sponsor
The Preventive Treatment of Migraine With Low-Dose Naltrexone and Acetaminophen Combination
PHASE2Completed
12 participants
Started: Aug 25, 2017 · Completed: Jul 28, 2018
NCT03201393Lead Sponsor
Low-Dose Naltrexone and Acetaminophen Combination in the Treatment of Chronic Low Back Pain (ANODYNE-4)
PHASE2Completed
12 participants
Started: Aug 15, 2017 · Completed: Jul 26, 2018
NCT03185143Lead Sponsor
Low-Dose Naltrexone and Acetaminophen Combination and Sumatriptan in the Acute Treatment of Migraine With Nausea
PHASE2/PHASE3Completed
36 participants
Started: Jun 27, 2017 · Completed: May 7, 2018
Locations (1)
Headquarters
North Miami, FL, United States
Map
Loading map...